Aptevo Therapeutics Inc. (APVO)

Aptevo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	21.06	8.71	16.9	22.64	45.04	39.98
Cash & Short-Term Investments	21.06	8.71	16.9	22.64	45.04	39.98
Cash Growth	171.65%	-48.45%	-25.32%	-49.75%	12.67%	221.17%
Accounts Receivable	-	-	-	2.5	3.66	2.37
Receivables	-	-	-	2.5	3.66	2.37
Prepaid Expenses	1.51	1.69	1.47	1.57	1.82	2.23
Restricted Cash	-	-	-	-	1.26	2.56
Other Current Assets	0.08	0.26	0.69	0.74	0.78	0.13
Total Current Assets	22.65	10.66	19.07	27.45	52.57	47.26
Property, Plant & Equipment	4.35	4.93	5.78	6.77	3.96	5.54
Other Long-Term Assets	-	-	-	-	0.07	0.75
Total Assets	27	15.59	24.84	34.22	56.6	53.55
Accounts Payable	2.22	3.05	3.98	3.5	3.46	5.58
Accrued Expenses	1.9	1.86	2.1	2.11	2.08	2.76
Current Portion of Long-Term Debt	-	-	-	2	11.67	5
Current Portion of Leases	0.8	0.77	-	0.42	-	-
Current Unearned Revenue	-	-	-	-	15.47	-
Other Current Liabilities	0.69	0.53	1.14	0.68	2.09	1.2
Total Current Liabilities	5.61	6.21	7.22	8.71	34.76	14.54
Long-Term Debt	-	-	-	1.46	3.71	20.05
Long-Term Leases	3.99	4.63	5.4	6.08	1.34	2.36
Long-Term Unearned Revenue	-	-	-	-	15.58	-
Total Liabilities	9.6	10.84	12.62	16.24	55.39	36.95
Common Stock	0.11	0.08	0.06	0.05	0.05	0.05
Additional Paid-In Capital	286.5	252.25	235.61	223.96	215.23	202.15
Retained Earnings	-269.22	-247.58	-223.45	-206.04	-214.06	-185.61
Shareholders' Equity	17.39	4.76	12.22	17.97	1.22	16.59
Total Liabilities & Equity	27	15.59	24.84	34.22	56.6	53.55
Total Debt	4.79	5.4	5.4	9.96	16.72	27.41
Net Cash (Debt)	16.27	3.32	11.51	12.68	28.33	12.57
Net Cash Growth	631.94%	-71.18%	-9.24%	-55.24%	125.46%	-
Net Cash Per Share	11.36	240.17	-	-	-	-
Filing Date Shares Outstanding	16.85	0.07	-	-	-	-
Total Common Shares Outstanding	13.81	0.07	-	-	-	-
Working Capital	17.04	4.45	11.84	18.74	17.81	32.73
Book Value Per Share	1.26	65.21	-	-	-	-
Tangible Book Value	17.39	4.76	12.22	17.97	1.22	16.59
Tangible Book Value Per Share	1.26	65.21	-	-	-	-
Machinery	-	12.26	12.26	12.26	12.43	11.73
Leasehold Improvements	-	2.23	2.23	2.23	2.23	2.23

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q